Laurus Labs FY26 revenue rises 23% to Rs 6,813 Crore; EBITDA surges 64%
Strong CDMO growth, improved product mix and operational leverage drive profitability expansion
Strong CDMO growth, improved product mix and operational leverage drive profitability expansion
The association is intended to strengthen healthcare delivery standards, particularly in Oncology services, and enhance patient care outcomes
Collaboration to accelerate mRNA neoantigen therapy development for colorectal and pancreatic cancers using advanced immunology and dark genome insights
EUDRAGIT polymers remain a cornerstone technology in oral drug delivery
With big pharma leaning on external pipelines, the company sees opportunity in de-risked, high-impact assets with clear clinical endpoints
The agreements aim to strengthen medicine quality, patient safety and pharmaceutical research in India
Platform integrates VR simulations and AI-driven coaching to build job-ready skills in pharma manufacturing
Targets high-growth eye care expansion push
The conclave brought together over 1,000 delegates from across India and internationally
Subscribe To Our Newsletter & Stay Updated